Pharmacological management of gabaergic neurons survival in ischemic conditions: the role of a novel hydroxypyridine compound

Р. М. Термулаева, Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), E. V. Blinova(Sechenov University), Д. Е. Тимошкин, Е В Семелева, D.O. Shmatok, А. А. Дмитриев(National Research Mordovia State University), N. D. Bunyatyan(Belgorod National Research University), O. N. Deryabina(National Research Mordovia State University), И. В. Федосейкин(Sechenov University)
Drug development & registration
April 27, 2026
10.33380/2305-2066-2026-15-2-2318
Cited by 0

Related Papers

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13
Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model
|Biochemical and Biophysical Research Communications|2025|12